[Treatment of arterial hypertension after ischemic cerebral stroke]

Area of Science:

• Neurology
• Cardiology
• Public Health

Context:

• Secondary cerebral strokes carry a higher lethality rate compared to primary strokes.
• Clinical data on arterial hypertension management post-stroke are often contradictory.
• Recent research links repeated ischemic stroke risk directly to systolic and diastolic blood pressure (BP).

Purpose:

• To review the complex relationship between blood pressure control and secondary stroke prevention.
• To explore the effectiveness of various antihypertensive drug classes in preventing recurrent strokes.
• To highlight the potential non-hypotensive mechanisms of antihypertensive drugs in stroke prevention.

Summary:

• The optimal blood pressure (BP) level for preventing secondary stroke varies by stroke type, emphasizing the need to maintain cerebral perfusion via autoregulation.
• While BP reduction degree correlates with lowered secondary stroke risk, data on specific antihypertensive drug classes remain inconsistent.
• The MOSES study is noted as a key comparison of antihypertensive classes, suggesting mechanisms beyond simple BP lowering may be at play.
• Carotid atherosclerosis can complicate cerebral perfusion, increasing stroke risk, especially with aggressive BP lowering.

Impact:

• Informs clinical guidelines for post-stroke hypertension management.
• Highlights the need for further research into drug-specific effects beyond BP reduction.
• Contributes to understanding the multifactorial nature of secondary stroke prevention.
• Emphasizes personalized treatment strategies considering individual patient factors like atherosclerosis.